Talea Group SpA is an online retailer of heath and wellness products in Italy. The product categories of the company include over-the-counter drugs; orthopedics and aids; homeopathic products; para pharmaceuticals; medical devices; products for children; herbal; diet products and pet products among others.
2012
44
LTM Revenue n/a
LTM EBITDA n/a
$67.2M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Talea Group has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Talea Group achieved revenue of $141M and an EBITDA of -$4.0M.
Talea Group expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Talea Group valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $125M | $141M | XXX | XXX | XXX |
Gross Profit | $29.8M | $41.2M | XXX | XXX | XXX |
Gross Margin | 24% | 29% | XXX | XXX | XXX |
EBITDA | $2.2M | -$4.0M | XXX | XXX | XXX |
EBITDA Margin | 2% | -3% | XXX | XXX | XXX |
Net Profit | -$0.1M | -$1.0M | XXX | XXX | XXX |
Net Margin | 0% | -1% | XXX | XXX | XXX |
Net Debt | $12.0M | $19.5M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Talea Group's stock price is EUR 4 (or $5).
Talea Group has current market cap of EUR 37.2M (or $40.0M), and EV of EUR 62.5M (or $67.2M).
See Talea Group trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$67.2M | $40.0M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Talea Group has market cap of $40.0M and EV of $67.2M.
Talea Group's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Talea Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Talea Group and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $67.2M | XXX | XXX | XXX |
EV/Revenue | 0.5x | XXX | XXX | XXX |
EV/EBITDA | -16.8x | XXX | XXX | XXX |
P/E | -5.0x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | -4.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpTalea Group's NTM/LTM revenue growth is n/a
Talea Group's revenue per employee for the last fiscal year averaged $3.2M, while opex per employee averaged $0.9M for the same period.
Over next 12 months, Talea Group's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Talea Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Talea Group and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 13% | XXX | XXX | XXX | XXX |
EBITDA Margin | -3% | XXX | XXX | XXX | XXX |
EBITDA Growth | -284% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
Revenue per Employee | $3.2M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.9M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 18% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 5% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 28% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
MedPlus India | XXX | XXX | XXX | XXX | XXX | XXX |
Pague Menos | XXX | XXX | XXX | XXX | XXX | XXX |
Droga Raia | XXX | XXX | XXX | XXX | XXX | XXX |
Redcare Pharmacy | XXX | XXX | XXX | XXX | XXX | XXX |
Oriola | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Talea Group acquired XXX companies to date.
Last acquisition by Talea Group was XXXXXXXX, XXXXX XXXXX XXXXXX . Talea Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Talea Group founded? | Talea Group was founded in 2012. |
Where is Talea Group headquartered? | Talea Group is headquartered in Italy. |
How many employees does Talea Group have? | As of today, Talea Group has 44 employees. |
Who is the CEO of Talea Group? | Talea Group's CEO is Mr. Riccardo Lacometti. |
Is Talea Group publicy listed? | Yes, Talea Group is a public company listed on MIL. |
What is the stock symbol of Talea Group? | Talea Group trades under TALEA ticker. |
When did Talea Group go public? | Talea Group went public in 2019. |
Who are competitors of Talea Group? | Similar companies to Talea Group include e.g. MedPlus India, Pague Menos, Droga Raia, Redcare Pharmacy. |
What is the current market cap of Talea Group? | Talea Group's current market cap is $40.0M |
What is the current revenue growth of Talea Group? | Talea Group revenue growth between 2023 and 2024 was 13%. |
Is Talea Group profitable? | Yes, Talea Group is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.